ARTICLE | Clinical News
Ofev nintedanib regulatory update
February 9, 2015 8:00 AM UTC
The European Commission approved Ofev nintedanib from Boehringer to treat idiopathic pulmonary fibrosis (IPF). The drug is approved as Vargatef in the EU in combination with docetaxel to treat locally...